An Innovative Therapeutic Protocol for Vitiligo: Experience with the Use of Fraxel Herbium Laser, Topical Latanoprost and Successive Irradiation with UVA - 1 Laser

Authors

  • Torello Lotti University G. Marconi of Rome, Dermatology and Venereology, Rome
  • Uwe Wollina Städtisches Klinikum Dresden, Department of Dermatology and Venereology, Dresden, Sachsen
  • Georgi Tchernev Medical Institute of Ministry of Interior Department of General, Vascular and Abdominal Surgery, Sofia; Onkoderma - Policlinic for Dermatology and Dermatologic Surgery, Sofia
  • Yan Valle Vitiligo Research Foundation, New York
  • Jacopo Lotti University G. Marconi of Rome - Dept. of Nuclear, Subnuclear and Radiation Physics, Rome
  • Katlein França University of Miami School of Medicine, Miami, Florida 33136-1015
  • Francesca Satolli Universita degli Studi di Parma Dipartimento di Medicina Clinica e Sperimentale, Department of Dermatology, University of Parma, Parma
  • Miriam Rovesti Universita degli Studi di Parma Dipartimento di Medicina Clinica e Sperimentale, Department of Dermatology, University of Parma, Parma
  • Michael Tirant Psoriasis & Skin Clinic, 374 Nepean Highway Frankston Victoria, Melbourne
  • Ilia Lozev Medical Institute of Ministry of Interior, Department of General, Vascular and Abdominal Surgery,General Skobelev 79, 1606 Sofia
  • Ivan Pidakev Medical Institute of Ministry of Interior, Department of General, Vascular and Abdominal Surgery,General Skobelev 79, 1606 Sofia
  • Serena Gianfaldoni University G. Marconi of Rome - Dermatology and Venereology, University G. Marconi of Rome, Rome

DOI:

https://doi.org/10.3889/oamjms.2018.059

Keywords:

Vitiligo, Fraxel Herbium laser, Latanoprost, UVA1 laser, Repigmentation

Abstract

Despite the continuous introduction of innovative therapies for vitiligo, today none of them provide constant and excellent results in term of repigmentation. The authors report their experience in treating a localised form of vitiligo with a new protocol consisting in the use of a Fraxel Herbium laser, and in the following application of topical Latanoprost solution and, one day after, in lesional irradiation with UVA1 laser.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Lotti T, Hautmann G, Hercogovà J. Vitiligo: disease or symptom? From the confusion of the past to current doubts. In: Lotti T, Hercogovà J, eds. Vitiligo. Problems and solutions. New York, NY, Basel: Marcel Dekker, Inc., 2004:1-14. PMid:15063608

Lotti T, Hanna D, Buggiani G, Urple M. The colour of the skin: psycho-anthropologic implications. J Cosmet Dermatol. 2005; 4(3):219-20. https://doi.org/10.1111/j.1473-2165.2005.00316.x PMid:17129270

Colucci R, Lotti T, Moretti S. Vitiligo: an update on current pharmacotherapy and future directions. Expert Opin Pharmacother. 2012; 13:1885-1899. https://doi.org/10.1517/14656566.2012.712113 PMid:22835073

Wassef C, Lombardi A, Khokher S, Rao BK. Vitiligo surgical, laser, and alternative therapies: a review and case series. J Drugs Dermatol. 2013; 12(6):685-91. PMid:23839187

Lotti T, Hercogova J, Wollina U, Chokoeva AA, Zarrab Z, Gianfaldoni S, Roccia MG, Fioranelli M, Tchernev G. Vitiligo: successful combination treatment based on oral low dose cytokines and different topical treatments. J Biol Regul Homeost Agents. 2015; 29(Suppl 1):53-8. PMid:26016984

Yan R, Yuan J, Chen H, Li YH, Wu Y, Gao XH, Chen HD. Fractional Er: YAG laser is assisting topical betamethasone solution in combination with NB-UVB for resistant non- segmental vitiligo. Lasers Med Sci. 2017. https://doi.org/10.1007/s10103-017-2282-y

Anbar TS, El-Ammawi TS, Abdel-Rahman AT, Hanna MR. The effect of latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol. 2015; 54(5):587-93. https://doi.org/10.1111/ijd.12631 PMid:25545321

Korobko IV, Lomonosov KM. A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo. Dermatol Ther. 2016; 29(6):437-441. https://doi.org/10.1111/dth.12383 PMid:27329330

Lotti TM, Hercogova J, D'Erme AM et Al. UVA-1in dermatology: clinical studies and observations. In UVA1 in dermatology. Evidence, data, hypotheses. Nuova Prhomos Publishing House Italy, 2013:74-160.

Babino G, Giunta A, Esposito M, Saraceno R, Pavlidis A, Del Duca E, Chimenti S, Nisticò SP. UVA1 Laser in the Treatment of Vitiligo. Photomed Laser Surg. 2016; 34(5):200-4. https://doi.org/10.1089/pho.2015.4004 PMid:27070209

Published

2018-01-21

How to Cite

1.
Lotti T, Wollina U, Tchernev G, Valle Y, Lotti J, França K, Satolli F, Rovesti M, Tirant M, Lozev I, Pidakev I, Gianfaldoni S. An Innovative Therapeutic Protocol for Vitiligo: Experience with the Use of Fraxel Herbium Laser, Topical Latanoprost and Successive Irradiation with UVA - 1 Laser. Open Access Maced J Med Sci [Internet]. 2018 Jan. 21 [cited 2021 Apr. 11];6(1):49-51. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.059

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>